1998
DOI: 10.1002/(sici)1099-1654(199807/09)8:3<153::aid-rmv228>3.0.co;2-y
|View full text |Cite
|
Sign up to set email alerts
|

Lamivudine treatment of chronic hepatitis B

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1999
1999
2005
2005

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…It remains to be seen whether the positive effect of lamivudine will be durable or whether maintenance lamivudine therapy will be required. Dosages of 100 mg of lamivudine per day have resulted in sustained HBeAg seroconversion rates of 27% and histologic improvement rates of up to 50% after 2 years of therapy in immunocompetent patients, but mutations in the YMDD motif of the viral polymerase gene, leading to antiviral resistance, develop in up to one third of patients [25]. These mutations do not seem to confer cross-resistance to other antiviral agents [26].…”
Section: Treatmentmentioning
confidence: 99%
“…It remains to be seen whether the positive effect of lamivudine will be durable or whether maintenance lamivudine therapy will be required. Dosages of 100 mg of lamivudine per day have resulted in sustained HBeAg seroconversion rates of 27% and histologic improvement rates of up to 50% after 2 years of therapy in immunocompetent patients, but mutations in the YMDD motif of the viral polymerase gene, leading to antiviral resistance, develop in up to one third of patients [25]. These mutations do not seem to confer cross-resistance to other antiviral agents [26].…”
Section: Treatmentmentioning
confidence: 99%
“…Overall only 30-40% of white adults have a sustained response to interferon therapy. 1 Similar response rates can be achieved in Asian patients, but only if the patients are carefully selected on evidence of continuing viral replication and liver damage. [2][3][4] Antiviral agents are therefore being investigated as possible alternative treatment options.…”
Section: Treatment Options For Chronic Hepatitismentioning
confidence: 97%
“…Overall only 30-40% of white adults have a sustained response to interferon therapy 1. Similar response rates can be achieved in Asian patients, but only if the patients are carefully selected on evidence of continuing viral replication and liver damage 24.…”
mentioning
confidence: 98%